Skip to content

An Acupuncture Study for People At High Risk for Sepsis

Acupuncture to Improve Outcomes in Sepsis Patient: The ACTIONS Trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06344819
Acronym
ACTIONS
Enrollment
78
Registered
2024-04-03
Start date
2024-03-20
Completion date
2028-03-20
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

sepsis, acupuncture

Brief summary

Researchers think acupuncture may improve outcomes for participants with sepsis, based on laboratory studies and previous studies in people with sepsis. The purpose of this study to see whether real acupuncture can improve outcomes for participants with sepsis when compared to sham acupuncture. Sham acupuncture is performed the same way as real acupuncture but will use different needles and target different sites or places on the body than real acupuncture.

Interventions

PROCEDUREAcupuncture

Acupuncture involves insertion of thin filiform needles (gauze 30-40) at certain points on the body.

OTHERSham Acupuncture

During sham acupuncture, a point on the participant's ankle is gently tapped with an acupuncture needle guide tube and an acupuncture needle is taped flat to the skin. This point is not on any acupuncture meridian or point. Electrical stimulation device is connected to the needles, but no electrical stimulation is delivered.

Sponsors

University of California, Irvine
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Patient's inpatient clinical care team.

Intervention model description

RCT of true vs sham acupuncture

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * Having a sepsis order-set placed within the previous 48 hours

Exclusion criteria

* The study Principal Investigator will review the medical record again prior to enrollment to exclude non-sepsis patients (Even though the placement of sepsis order set already screens out such patients, subsequent clinical development after sepsis order set placement may generate new information that deems the patient not septic.) * Admitted to ICU before being approached for consenting * Having an implanted medical device, such as a pacemaker or implantable cardioverter-defibrillator (ICD), with which electroacupuncture * Unable to obtain informed consent due to a participant's mental status and absence of an individual authorized to give consent on the participant's behalf * The patient is on an interventional clinical trial and its Principal Investigator does not give approval to enrollment to this study (e.g. genomic profiling, biospecimen, or observational studies do not require PI approval).

Design outcomes

Primary

MeasureTime frameDescription
Number of participants recruited compared to the number of participants who complete study treatment.Up to 2 yearsTo assess the feasibility of conducting a randomized controlled trial of acupuncture in hospitalized patients who are at risk for sepsis.
Admission/transfer to ICUWithin 30 daysDeterioration of a participant's clinical condition that necessitate an admission or transfer to an Intensive Care Unit (ICU)

Secondary

MeasureTime frameDescription
Mortality30 daysDeath within 30 days in the same hospitalization

Countries

United States

Contacts

CONTACTGary Deng, MD, PhD
garyd2@hs.uci.edu949-824-7000
CONTACTGeorgia Christodoulou, PhD
gchrist3@hs.uci.edu
PRINCIPAL_INVESTIGATORGary Deng, MD, PhD

University of California, Irvine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026